Phase 3 Readout~month
Phase 3 Topline: A Multicenter, Prospective, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study Perf
- Company
- MediWound Ltd. (MDWD)
- Indication
- Venous Leg Ulcer (VLU)
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.